Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingObservational

UNC Metastatic Cancer Radiation Therapy Registry

NCT ID: NCT06306924Sponsor: UNC Lineberger Comprehensive Cancer CenterLast updated: 2026-05-06

Summary

The purpose of this registry is to collect clinical data from participants attending UNC Hospitals who present with metastatic cancer and are evaluated to receive radiation therapy as part of their standard of care treatment. The goal of this study is to provide a foundation for studies designed to identify projects across the translational continuum related to metastatic cancer and radiation therapy treatment. The relevant clinical data will be linked to patient-reported outcomes (PROs) thus allowing for a unique and robust dataset. Ultimately, this registry will provide current and future studies with the ability to analyze the correlation of radiation therapy regimens with metastatic cancer outcomes.

Arms & interventions

  • RadiationRadiation therapy

    Subjects with metastatic cancer receive radiation therapy.

Outcome measures

Primary

  • Clinical Data

    Clinical data and radiological assessments from participants with metastatic cancer receiving radiation therapy as a part of the standard of care will be collected.

    Time frame: Up to 1 month

Secondary

  • Patient reported outcomes (PRO)

    Time frame: Baseline, 1 month, 3 months, 6 months, 9 months, and 12 months

Eligibility criteria

Sex: AllAge: 18 Years and older
Inclusion Criteria: Written informed consent was obtained to participate in the study and HIPAA Authorization for release of personal health information. Ability to understand and willingness to sign informed consent Diagnosed with or is suspected to have metastatic cancer. Age ≥ 18 years at the time of consent. Evaluated to receive radiation therapy as part of their standard-of-care treatment plan. Exclusion Criteria: All participants must not meet any of the following exclusion criteria prior to enrollment to participate in this study: Any serious medical or psychiatric disorder that would interfere with the participant's ability to give informed consent.

Study locations (1)

Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill

Chapel Hill, North Carolina, 27599

Recruiting
Shivani Sud, MS · Contact
919-918-5924sshivani.sud@unchealth.unc.edu
Shivani Sud, MD · Principal Investigator
UNC Metastatic Cancer Radiation Therapy Registry | Cancerify